Overview strategies for blood donor selection vCJD
Several recent publications on transfusion risk assessment of variant Creutzfeldt-Jakob disease (vCJD) have led to changes in donor selection criteria[…]
Several recent publications on transfusion risk assessment of variant Creutzfeldt-Jakob disease (vCJD) have led to changes in donor selection criteria[…]
Read the full article in the Transfusion journal. Background New blood products are considered for treatment of patients with major[…]
On December 9th, the European Blood Alliance (EBA) presented the “Implementation of Whole Blood for Transfusion” webinar, supported by the[…]
Read the full article in Vox Sanquinis Background and Objectives DEHP, di(2-ethylhexyl) phthalate, is the most common member of the[…]
Since 2015 the EUFRAT risk assessment tool has been publicly available on the website of the European Centre for Disease[…]